1
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Condition(s):Heart FailureLast Updated:August 27, 2020Active, not recruiting
Empagliflozin: 250 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Empagliflozin in Post-Transplantation Diabetes Mellitus
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
3
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
Condition(s):Diabetic NephropathiesLast Updated:May 20, 2020Suspended
4
Empagliflozin and Renal Oxygenation in Healthy Volunteers
Condition(s):NephropathyLast Updated:July 30, 2019Completed
5
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
Condition(s):Type 2 Diabetes MellitusLast Updated:June 16, 2020Not yet recruiting
6
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Condition(s):Diabetes Mellitus Type 2Last Updated:May 15, 2018Completed
7
Effect of Empagliflozin on Ventricular Repolarization.
Condition(s):Diabetes Mellitus, Type 2; Coronary Heart Disease; Arrythmia, CardiacLast Updated:April 7, 2020Recruiting
8
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:August 15, 2019Completed
9
Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)
Condition(s):Type 2 Diabetes; Cardiovascular Risk FactorLast Updated:December 3, 2019Recruiting
10
Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
Condition(s):Diabetes Mellitus, Type 2; Diastolic DysfunctionLast Updated:August 12, 2019Recruiting